The Company is a Korea-based company mainly engaged in the provision of diagnostic testing services. The Company is involved in the provision of the general diagnostic testing services, molecular diagnostic testing services, as well as medical information technology (IT) services. The general diagnostic testing services include the provision of diagnosis and inspection information such as immunological serology, hematology, urine and microbiology, and pathology excluding molecular diagnostics among in vitro diagnostic tests. The Molecular diagnostic testing services include the provision of diagnostic and testing information through tests such as urethritis, mastoiditis, vaginitis, and cervicitis. The medical IT services include the provision of customized medical services through software products. The Company was founded on January 02, 2009. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on Jun 29, 2015.
Headquarters
65, Geoma-Ro, Songpa-Gu
Seoul; Seoul;
Contact Details: Purchase the U2Bio Co. Ltd. report to view the information.
Website: http://www.u2bio.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service